Company Valuation: IRADIMED CORPORATION

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 570.3 355.5 598.4 697 1,238 1,016 - -
Change - -37.67% 68.32% 16.49% 77.54% -17.93% - -
Enterprise Value (EV) 570.3 355.5 598.4 697 1,238 1,016 1,016 1,016
Change - -37.67% 68.32% 16.49% 77.54% -17.93% 0% 0%
P/E 62.4x 27.7x 35.2x 36.7x 55.6x 41.4x 35.2x 32.4x
PBR - - - - - - - -
PEG - 0.7x 1.1x 3.3x 3.3x 4.35x 2x 3.71x
Capitalization / Revenue 13.6x 6.67x 9.13x 9.52x 14.8x 11x 9.93x 9.15x
EV / Revenue 0x 0x 0x 0x 0x 11x 9.93x 9.15x
EV / EBITDA - - - - - 29.4x 27.4x 24.2x
EV / EBIT 0x 0x 0x 0x 0x 33.4x 29.3x 26.8x
EV / FCF - - - - - 41.3x 36.8x 31.2x
FCF Yield - - - - - 2.42% 2.72% 3.21%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 0.74 1.02 1.35 1.5 1.75 1.917 2.253 2.45
Distribution rate - - - - - - - -
Net sales 1 41.81 53.3 65.56 73.24 83.81 92.05 102.3 111
EBITDA 1 - - - - - 34.5 37.1 42
EBIT 1 9.818 15.63 20.04 21.96 26.15 30.4 34.63 37.85
Net income 1 9.325 12.83 17.19 19.23 22.48 24.63 28.45 31.65
Net Debt - - - - - - - -
Reference price 2 46.21 28.29 47.47 55.00 97.28 79.42 79.42 79.42
Nbr of stocks (in thousands) 12,342 12,566 12,606 12,673 12,721 12,788 - -
Announcement Date 2/4/22 A 2/2/23 A 2/8/24 A 2/13/25 A 2/10/26 A - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
41.44x - - - 1.02B
34.96x5.97x22.82x0.27% 253B
36.24x6.89x21.57x0.64% 160B
50.32x12.19x26.16x-.--% 151B
18.13x3.61x11.78x-.--% 64.23B
21.25x2.53x12.78x2.38% 54.11B
36.97x7.41x23.45x-.--% 53.76B
47x11.56x25.47x-.--% 49.71B
33.51x6.64x22.56x0.6% 48.49B
78.69x7.5x22.76x-.--% 44.17B
Average 39.85x 7.15x 21.04x 0.43% 88.02B
Weighted average by Cap. 38.69x 7.34x 21.92x 0.37%

Y-o-Y evolution of P/E

Valuation ratios - P/E - IRADIMED CORPORATION

Historical PBR trend

Valuation ratios - PBR - IRADIMED CORPORATION

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - IRADIMED CORPORATION

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - IRADIMED CORPORATION

  1. Stock Market
  2. Stocks
  3. IRMD Stock
  4. Valuation IRADIMED CORPORATION